ES2175573T3 - Procedimiento y compuestos intermedios para la preparacion de bencensulfonato de amlodipina. - Google Patents

Procedimiento y compuestos intermedios para la preparacion de bencensulfonato de amlodipina.

Info

Publication number
ES2175573T3
ES2175573T3 ES98115155T ES98115155T ES2175573T3 ES 2175573 T3 ES2175573 T3 ES 2175573T3 ES 98115155 T ES98115155 T ES 98115155T ES 98115155 T ES98115155 T ES 98115155T ES 2175573 T3 ES2175573 T3 ES 2175573T3
Authority
ES
Spain
Prior art keywords
metil
preparation
formula
bencensulfonate
amlodipine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98115155T
Other languages
English (en)
Inventor
Daniel Dr Bozsing
Gyorgyi Lax Dr Kovanyi
Gyula Dr Simig
Gyorgy Krasznai
Gabor Dr Blasko
Peter Dr Tompe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar, Egis Pharmaceuticals PLC filed Critical Egyt Gyogyszervegyeszeti Gyar
Application granted granted Critical
Publication of ES2175573T3 publication Critical patent/ES2175573T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/716—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

EL OBJETO DE LA PRESENTE INVENCION ES UN PROCESO PARA LA PREPARACION DE LA SAL DEL ACIDO 3 - [ETIL] - 5 - [METIL] - 2 [2'' - (AMINOETOXI) - METIL] - 4 - [2'''' - (CLORO) - FENIL] - 6 [METIL] - 1,4 - DI - [HIDRO] - PIRIDIN - 3,5 - DI - [CARBOXILATO] - BENCENSULFONICO DE FORMULA I EN LA QUE EL YODURO DE 3 [ETIL] - 5 - [METIL] - 2 - [2'' - (IL) ETOXI - METIL] - 4 - [2'''' - (CLORO) - FENIL] - 6 - [METIL] - 1,4 DI - [HIDRO] - PIRIDIN - 3,5 - DI - [CARBOXILATO] - HEXAMINIO DE FORMULA XI SE HACE REACCIONAR CON ACIDO BENCENSULFONICO DE FORMULA XII. ALGUNAS VARIANTES COMPRENDEN IGUALMENTE REACCIONES PARA PREPARAR INTERMEDIOS QUE LLEVEN AL CITADO PRODUCTO FINAL. UN OBJETO ADICIONAL DE LA INVENCION ES OBTENER LOS PRODUCTOS PARA LA PREPARACION DEL CITADO PRODUCTO FINAL.
ES98115155T 1997-08-12 1998-08-12 Procedimiento y compuestos intermedios para la preparacion de bencensulfonato de amlodipina. Expired - Lifetime ES2175573T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9701379A HU221810B1 (hu) 1997-08-12 1997-08-12 Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei

Publications (1)

Publication Number Publication Date
ES2175573T3 true ES2175573T3 (es) 2002-11-16

Family

ID=89995490

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98115155T Expired - Lifetime ES2175573T3 (es) 1997-08-12 1998-08-12 Procedimiento y compuestos intermedios para la preparacion de bencensulfonato de amlodipina.

Country Status (13)

Country Link
US (1) US6046337A (es)
EP (1) EP0902016B1 (es)
AT (1) ATE216988T1 (es)
CZ (1) CZ291430B6 (es)
DE (1) DE69805143T2 (es)
ES (1) ES2175573T3 (es)
HR (1) HRP980440B1 (es)
HU (1) HU221810B1 (es)
PL (2) PL191995B1 (es)
RU (1) RU2163597C2 (es)
SI (1) SI0902016T1 (es)
SK (1) SK283422B6 (es)
UA (1) UA57722C2 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA72768C2 (en) * 1999-07-05 2005-04-15 Richter Gedeon Vegyeszet A method for obtaining amilodipine benzenesulphonate
US7266501B2 (en) * 2000-03-02 2007-09-04 Akiba Electronics Institute Llc Method and apparatus for accommodating primary content audio and secondary content remaining audio capability in the digital audio production process
EP1309556B1 (en) 2000-12-29 2004-11-24 Pfizer Limited Amlodipine fumarate
EP1309557B9 (en) 2000-12-29 2006-11-15 Pfizer Limited Amlodipine hemimaleate
GB2371862B (en) * 2000-12-29 2004-07-14 Bioorg Bv Reference standards for determining the purity or stability of amlodipine maleate and processes therefor
MXPA03005882A (es) * 2000-12-29 2005-04-19 Pfizer Ltd Derivado amida de amlodipina.
BR0116557A (pt) * 2000-12-29 2003-10-28 Pfizer Ltd Processo, processo para fabricação de um sal de maleato de amlodipina substancialmente livre de aspartato de amlodipina, processo para purificação, maleato de amlodipina, composição farmacêutica para tratar ou prevenir angina ou hipertenção, método para tratar hipertenção, angina ou ataque cardìaco, benzeno sulfonato de amlodipina, hidrocloreto de amlodipina e uso de maleato de amlodipina substancialmente livre de aspartato de amlodipina
US6653481B2 (en) * 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
US7335380B2 (en) 2000-12-29 2008-02-26 Synthon Ip Inc. Amlodipine free base
WO2002053541A1 (en) * 2000-12-29 2002-07-11 Pfizer Limited Amide derivative of amlodipine
AT5874U1 (de) 2000-12-29 2003-01-27 Bioorg Bv Pharmazeutische zubereitungen enthaltend amlodipinmaleat
GB2372036B (en) 2000-12-29 2004-05-19 Bioorg Bv Aspartate derivative of amlodipine
KR100374767B1 (ko) * 2001-03-13 2003-03-03 한미약품공업 주식회사 개선된 암로디핀의 제조 방법
EP1435954B1 (en) * 2001-07-06 2010-01-13 LEK Pharmaceuticals D.D. A PROCESS FOR THE PREPARATION OF HIGHlLY PUREAMLODIPINE BENZENESULFONATE
US6680334B2 (en) 2001-08-28 2004-01-20 Pfizer Inc Crystalline material
US6828339B2 (en) * 2001-11-21 2004-12-07 Synthon Bv Amlodipine salt forms and processes for preparing them
US6699892B2 (en) 2002-06-04 2004-03-02 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salt of amlodipine and method of preparing the same
US6784297B2 (en) 2002-09-04 2004-08-31 Kopran Limited Process for the preparation of anti-ischemic and anti-hypertensive drug amlodipine besylate
US6608206B1 (en) * 2002-10-30 2003-08-19 Council Of Scientific & Industrial Research Process for making S(-) Amlodipine salts
WO2005089353A2 (en) * 2004-03-16 2005-09-29 Sepracor Inc. (s)-amlodipine malate
KR100807336B1 (ko) 2006-10-23 2008-02-28 명문제약주식회사 암로디핀의 제조를 위한 신규한 중간체 화합물, 이의 제조방법 및 이를 이용한 암로디핀의 제조 방법
HU230877B1 (hu) * 2008-09-30 2018-11-29 EGIS Gyógyszergyár NyR Stabil kombinációs gyógyszerkészítmény
CN102070516A (zh) * 2011-02-22 2011-05-25 广东东阳光药业有限公司 一种制备氨氯地平的方法
RU2755349C1 (ru) * 2021-02-16 2021-09-15 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Применение бензил 6-({ 2-[(3,4-диметилфенил)амино]-2-оксоэтил} тио)-2-метил-4-(4-хлорфенил)-5-циано-1,4-дигидропиридин-3-карбоксилата в качестве гепатопротекторного средства

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
US5001119A (en) * 1987-11-25 1991-03-19 Schwartz Arthur G 16-substituted androstanes and 16-substituted androstenes
US5352684A (en) * 1990-04-10 1994-10-04 Byk Gulden Lomberg Chemische Fabrik Gmbh Pyridines as medicaments
US5389654A (en) * 1992-11-26 1995-02-14 Lek, Tovarna, Farmacevtskih In Kemicnih . . . 3-ethyl 5-methyl(±)2-[2-(N-tritylamino)ethoxymethyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-6-methyl-3,5-pyridinedicarboxylate
SI9200344B (sl) * 1992-11-26 1998-06-30 Lek, Postopek za pripravo amlodipin benzensulfonata

Also Published As

Publication number Publication date
DE69805143T2 (de) 2002-11-28
SK104598A3 (en) 1999-03-12
UA57722C2 (uk) 2003-07-15
HRP980440B1 (en) 2003-06-30
SK283422B6 (sk) 2003-07-01
CZ291430B6 (cs) 2003-03-12
EP0902016A3 (en) 2000-01-05
US6046337A (en) 2000-04-04
PL327952A1 (en) 1999-02-15
ATE216988T1 (de) 2002-05-15
HUP9701379A3 (en) 2000-06-28
EP0902016B1 (en) 2002-05-02
HU9701379D0 (en) 1997-10-28
CZ239698A3 (cs) 1999-02-17
HUP9701379A2 (hu) 2000-05-28
PL191995B1 (pl) 2006-08-31
RU2163597C2 (ru) 2001-02-27
HRP980440A2 (en) 1999-06-30
PL192097B1 (pl) 2006-08-31
DE69805143D1 (de) 2002-06-06
SI0902016T1 (en) 2002-08-31
EP0902016A1 (en) 1999-03-17
HU221810B1 (hu) 2003-01-28

Similar Documents

Publication Publication Date Title
ES2175573T3 (es) Procedimiento y compuestos intermedios para la preparacion de bencensulfonato de amlodipina.
AR023275A1 (es) Derivados de la purina
AR027437A1 (es) Derivados de purina
ES2148588T3 (es) Procedimiento de destilacion reactiva para la produccion de acido acetico y metanol a partir de la hidrolisis de acetato de metilo.
GB8419963D0 (en) Intermediate compound and method
PA8528501A1 (es) Derivados de purina
GR3030466T3 (en) Platelet activating factor antagonists.
BR8201535A (pt) Processo para a preparacao de triazolilmetil-oxiranos substituidos,bem como sua aplicacao
DE69022294D1 (de) N-Heteroaryl-purin-6-amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
HUT65277A (en) Process for producing carbamate derivatives of 4-amino-3-isoxazolidinones, 1-amino-1-cyclopropane-carboxylic acid analogs pyrrolo-indoles and benzofurano benzazepines and pharmaceutical preparations containing them
ES8703460A1 (es) Un procedimiento para preparar aminoacil-ladanos
DE3363593D1 (en) 2-nitro-ethene diamines, process for their preparation and their use as medicines
ZA854250B (en) Triazole antifungul agents
FR2392999A1 (fr) Nouveaux derives de l'acide 6-((aminosulfonyl)-phenyl)-1,2-dihydro-2-oxonicotinique utile comme medicament
MY101618A (en) Intermediates for the production of epipodophyloxin and related compounds and processes for the preparation and use thereof
ES8800227A1 (es) Un procedimiento para preparar derivados de azirino-pirrolo-indol-diona
GB1468129A (en) Triazoles and imidazoles
GR3005962T3 (es)
IL114866A0 (en) Process for the preparation of the (-)-n-methyl-n-Ú4-(4-phenyl-4-acetylaminopiperidin-1-yl-2-(3,4-dichlorophenyl) butyl¾ benzamide
PE20050052A1 (es) Un nuevo proceso para la preparacion de derivados de epotilona, nuevos derivados de epotilona, asi como nuevos productos intermediarios para el proceso
ES8603871A1 (es) Procedimiento para preparar 2- (fenetil) -5- (3,4-metilen- dioxi)-x-hidroxibencil) -pirrolidina
FR2432518A2 (fr) Derives de la ((quinolyl-4)-3 propyl-1)-4 piperidine utilisables comme medicaments
DE3461281D1 (en) +/- 2-((3,4-methylenedioxy)phenethyl)-5-((3-carboxamido-4-hydroxy)-alpha-hydroxybenzyl)pyrrolidines, pharmaceutical compositions containing them, process for their production and intermediates therefor
ECSP044969A (es) Sales de derivados del acido 1,2,3,4-tetrahidroquinolin-2-carboxilico
FI933652A0 (fi) Foerfarande foer framstaellning av 1-osubstituerade 3-aminopyrroler

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 902016

Country of ref document: ES